Million Health PharmaceuticalsMillion Health Pharmaceuticals

Sorafenat

Brand : Sorafenat

Price : 225

Strength : 200mg

Active : Sorafenat-Sorafenib-200mg

Description :

Therapeutic indications:

Sorafenat is indicated for the treatment of hepatocellular carcinoma for the treatment of patients with advanced renal cell carcinoma who have not responded to, or are not eligible for, interferon-alfa or interleukin-2 therapy for the treatment of differentiated thyroid carcinoma (Papillary / follicular / Hurthle cells) progressively, locally advanced or metastatic, refractory to radioiodine treatment.
Contraindications, precautions:

Treatment with Sorafenat... Read More

DESCRIPTION

Therapeutic indications:

Sorafenat is indicated for the treatment of hepatocellular carcinoma for the treatment of patients with advanced renal cell carcinoma who have not responded to, or are not eligible for, interferon-alfa or interleukin-2 therapy for the treatment of differentiated thyroid carcinoma (Papillary / follicular / Hurthle cells) progressively, locally advanced or metastatic, refractory to radioiodine treatment.
Contraindications, precautions:

Treatment with Sorafenat will be performed under the supervision of a specialist in anticancer therapy.

Dosage and administration :

The recommended dose for adults is 400 mg sorafenib (two 200 mg tablets) twice daily (equivalent to a total daily dose of 800 mg) under the supervision of a specialist in anticancer therapy.